Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients

NCT01288391 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia A
Haemophilia B

Interventions

DRUG: NNC 0128-0000-2011
DRUG: NNC 0128-0000-2011

Sponsor

Novo Nordisk A/S